Molecular Carcinogenesis · 2007 · 53 citations · 25 references
Life SciencesMedicinal ChemistryPharmacologyCarcinogenesisCell SignalingSignal TransductionCell Signaling NetworksEnzyme InhibitionGrowth Factor SignalingActivator Protein 1 ActivationActivator ProteinsFlavonoid Pathway RegulationFlavonoid-mediated Inhibition
We found that quercetin, myricetin, quercetagetin, fisetin, (-)-epigallocatechin gallate (EGCG), and theaflavins, among 24 flavonoids examined, markedly inhibited epidermal growth factor (EGF)-induced cell transformation of mouse epidermal JB6 Cl 41 cells. The six flavonoids suppressed the EGF-induced activation of activator protein 1 (AP-1). In addition, myricetin, quercetagetin, EGCG, and theaflavins directly inhibited EGF-induced phosphatidylinositol 3-kinase (PI3K) activation. The important structural features of flavonoids for cell transformation-inhibitory activity are 3'- and 4'-OH on the B-ring, 3-OH on the C-ring, C2=C3 double bond in the C-ring, and the phenylchromone (C6-C5-C6) skeleton in the flavonols, and the galloyl group in EGCG and theaflavins. Our results provide new insight into possible mechanisms of the anti-carcinogenic effects of flavonoids, and could help to provide a basis for the design of novel cancer chemopreventive agents.
25
The antitumor activities of flavonoids.
Chithan Kandaswami, Chithan Kanadaswami, Lung‐ta Lee et al. · PubMed · 2005 · 656 citations
Life Sciences, Botany, Oncology +13
Georgine Agullo, Laurence Gamet‐Payrastre, Stéphane Manenti et al. · Biochemical Pharmacology · 1997 · 536 citations